Family · Pharmaceutical analytical standards
Roflumilast
A selective inhibitor of phosphodiesterase 4 (PDE4), an enzyme involved in inflammation, approved in Europe in 2010 and in the United States in 2011 as a tablet for severe COPD with chronic bronchitis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?After the lungs it moved on to the skin: since 2022 the same molecule has been used as a cream, and later a foam, for psoriasis, seborrhoeic dermatitis and atopic dermatitis.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
